Male Factor Infertility Associated With Comorbidities
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Male Factor Infertility Associated With Comorbidities


ARNHEM, the Netherlands -- November 11, 2009 -- A study published in the December issue of the journal European Urology shows that male factor infertility is associated with a number of medical comorbidities, as objectively scored with the hospital-based Charlson Comorbidity Index (CCI).

Andrea Salonia, MD, Department of Urology, University Vita Salute San Raffaele Hospital, Milan, Italy, and colleagues conducted a prospective case-controlled study in 344 44 European Caucasian men aged 18 to 60 years with MFI.

“Because a greater prevalence of cancers among men with abnormalities in fertility has been reported, our hypothesis was that men with male factor infertility (MFI) may also suffer from a higher rate of certain disorders other than cancers when compared with the general, age-comparable fertile population,” said Dr. Salonia.

“The clinical observation of a significant rate of diseases among men with MFI prompted us to examine whether those patients are less healthy than age-comparable fertile men, as objectively scored with a comorbidity index, regardless of the reasons for infertility.”

From September 2006 to September 2007, the men with MFI were compared with a control group of 293 age-comparable fertile European Caucasian men.

Comorbidities of patients and fertile men were objectively scored with the CCI according to the International Classification of Diseases modified ninth version (ICD-9-CM) codes.

The study provides novel evidence that MFI accounts for a higher CCI, which may be considered a reliable proxy of a lower general health status, regardless of the etiology of pure MFI.

“Since the current sample size is limited, we cannot derive general conclusions; therefore, additional studies in larger population-based samples are needed to confirm these results,” said Dr. Salonia.

SOURCE: European Association of Urology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities